Burshtein Gregory (CIK 2026002) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-08). Recent activity: Buy ENTX (87,591 shares), Buy ENTX (26,316 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | Entera Bio Ltd. (ENTX) | Chief of R&D | Buy | 87,591 | $0 |
| 2025-07-18 | Entera Bio Ltd. (ENTX) | Chief of R&D | Buy | 26,316 | $0 |
Source: SEC Form 4 filings · as of 2026-05-08